This essay summarizes my views on (a) the foundations of portfolio theory and its
applications to current issues, such as the choice of criteria for practical risk-return analysis …

Worldwide human papillomavirus (HPV) prevalence in women with normal cytology at any
given point in time is approximately 10% indicating that HPV is one of the most common …

This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Virtually all cases of cervical cancer are caused by persistent infections with a restricted set
of human papillomaviruses (HPV). Some HPV types, like HPV16 and HPV18, are clear and …

Objective Thirteen human papillomavirus (HPV) genotypes are associated with the highest
risk of cervical disease/cancer; however, the risk of disease progression and cancer is …

This study evaluated the clinical performance of the cobas 4800 HPV Test (Roche Molecular
Systems, Pleasanton, CA) for high-risk human papillomavirus (HR-HPV) testing with …

High-risk human papillomaviruses (HPVs) cause essentially all cervical cancers, most anal
and oropharyngeal cancers, and some vaginal, vulvar, and penile cancers. Improved …

This ninetieth volume of the IARC Monographs on the Evaluation of Carcinogenic Risks to
Humansconsiders human papillomaviruses (HPVs) which were evaluated by a previous …

Background. Cervical cancer is caused by persistent infection with human papillomavirus
(HPV). Most infections and associated lesions clear spontaneously. It is important to define …

Background We evaluated the impact of a quadrivalent human papillomavirus (HPV)
vaccine on infection and cervical disease related to 10 nonvaccine HPV types (31, 33, 35 …